422 filings
Page 2 of 22
D
b9oyjg
4 Oct 23
$59.99 mm in equity / options / securities to be acquired, sold $59.99 mm, 14 investors
10:36am
8-K
p9pv2bleo90zip0hv
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
zap0f2j4sljpx8
29 Sep 23
Prospectus supplement for primary offering
4:51pm
FWP
o78yrtm4sgpid
28 Sep 23
Free writing prospectus
7:02am
FWP
x87wrqy4m1qhcrx0n
28 Sep 23
Free writing prospectus
7:00am
S-3MEF
gu0e bnqqj2
27 Sep 23
Registration of additional securities for an S-3
9:32pm
424B5
qzu15ppba
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
ma47nsgxu695 0b45
27 Sep 23
Termination of a Material Definitive Agreement
5:23pm
8-K
u50hv
26 Sep 23
Soleno Therapeutics Announces Positive Statistically Significant Top-line Results from
7:30am
8-K
7xc r1qw6e
16 Aug 23
Departure of Directors or Certain Officers
9:00am
S-8
0rrx7q7gxuteo
8 Aug 23
Registration of securities for employees
5:25pm
8-K
ww5jnyz0
8 Aug 23
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:25pm
EFFECT
dbvkj7smgq6w
3 Aug 23
Notice of effectiveness
12:15am
CORRESP
vcatd y0pe
31 Jul 23
Correspondence with SEC
12:00am
UPLOAD
82bbshg55nec2qe88vc
28 Jul 23
Letter from SEC
12:00am
8-K
3frare894xnlociknml
10 Jul 23
Regulation FD Disclosure
4:06pm